Silexion Therapeutics Corp
SLXN
$3.78
$0.051.34%
NASDAQ
| 12/31/2024 | 03/31/2024 | 12/31/2023 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -39.84% | -39.48% | -- | ||
| Total Receivables | -- | -- | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 2.33% | 38.81% | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -25.38% | 89.80% | -- | ||
| Total Current Assets | -26.16% | -32.94% | -- | ||
|
|
|||||
| Total Current Assets | -26.16% | -32.94% | -- | ||
| Net Property, Plant & Equipment | 1,500.00% | -12.55% | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 960.00% | 0.00% | -- | ||
| Total Assets | -7.26% | -31.79% | -- | ||
|
|
|||||
| Total Accounts Payable | 16.27% | -23.51% | -- | ||
| Total Accrued Expenses | -43.81% | -16.55% | -- | ||
| Short-term Debt | 338.43% | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | -- | -1.79% | -- | ||
| Total Finance Division Other Current Liabilities | -80.00% | 40.50% | -- | ||
| Total Other Current Liabilities | -80.00% | 40.50% | -- | ||
| Total Current Liabilities | -1.67% | -11.61% | -- | ||
|
|
|||||
| Total Current Liabilities | -1.67% | -11.61% | -- | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | 338.43% | -- | -- | ||
| Capital Leases | -- | -42.37% | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -- | -- | -- | ||
| Total Liabilities | -10.62% | -12.42% | -- | ||
|
|
|||||
| Common Stock & APIC | 6.11% | 0.28% | -- | ||
| Retained Earnings | -4.02% | -5.12% | -- | ||
| Treasury Stock & Other | -- | -- | -- | ||
| Total Common Equity | 12.88% | -8.67% | -- | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | 0.00% | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | 0.00% | -- | ||
|
|
|||||
| Total Common Equity | 12.88% | -8.67% | -- | ||
| Total Preferred Equity | -- | 0.00% | -- | ||
| Total Minority Interest | -- | -1.46% | -- | ||
| Total Equity | 12.88% | -46.35% | -- | ||
|
|
|||||